Zevra Therapeutics

At Zevra, our mission is clear: we redefine what is possible in bringing life-changing therapies to people living with rare diseases. Our values guide us every day, shaping how we work, collaborate, and stay focused on what matters most – patients and families. #RareDisease #CompanyCulture

Zevra Therapeutics reports first quarter 2026 financial results and provides a corporate update.   Join our LIVE webcast TODAY at 4:30 p.m. ET: https://lnkd.in/eS9MmUzz   For more, find the full release here:  https://lnkd.in/eSaz9KHi   #RareDiseases #InvestorRelations #IR 

We’re excited to share that Zevra Therapeutics was featured in PharmaBoardroom’s recent rare disease addition. The feature brings together key voices across the U.S. Food and Drug Administration, National Institutes of Health, policy and advocacy leaders, leading research institutions, and industry executives, all focused on advancing progress for the rare disease community. We’re honored to be included among stakeholders working to drive innovation, collaboration, and meaningful impact for patients and families. Read the full article here: https://lnkd.in/evY5nJ4J #RareDisease #HealthcareLeadership 

That’s a wrap on #AANAM! Our team enjoyed connecting with the neurology community and engaging with attendees at our booth. Thanks to everyone who stopped by. We’re excited by the momentum and look forward to what’s next.

Zevra Therapeutics will report first quarter 2026 financial results and provide a corporate update on Wednesday, May 6, 2026, with a live webcast at 4:30 p.m. ET. For registration details, see the release: https://lnkd.in/e4QeJrZk #RareDiseases #InvestorRelations #IR

Good luck to everyone running the 130th Boston Marathon today! Our team is cheering on all the runners, volunteers, and supporters who make this incredible day possible. Wishing you a strong race and great weather out there! #BostonMarathon #BostonStrong

We’re excited to attend the 2026 AAN Annual Meeting, April 18–22 in Chicago, IL. If you’re attending #AANAM, we invite you to stop by booth #4834 to connect and learn more about our ongoing efforts focused on Niemann-Pick disease type C (NPC). We look forward to engaging with clinicians, researchers, and advocates working to advance care and understanding of rare neurological diseases. 

Niemann-Pick disease type C (NPC) is a rare, progressive genetic disorder that affects patients and families every day. Understanding NPC starts with learning more and every bit of awareness helps support those living with it. Visit https://www.learnnpc.com to learn more about NPC and how you can help raise awareness. #RareDisease #NPC #NiemannPick #PatientCentricity 

April Fools’ may be a day for jokes, but for the rare disease community, every day is serious. At Zevra, we are committed to bringing life-changing therapies to people living with rare diseases. We honor the patients, families, and caregivers who face these challenges every day, and we are dedicated to raising awareness, advancing research, and delivering on our mission. Together, we work toward a future where rare disease is met with solutions, not compromise. #RareDisease #PatientCentricity #Awareness

For families living with VEDS, the DiSCOVER Trial represents hope for the future. Each participant helps accelerate rare disease science and help shape what could be next in vascular care. If you or someone you know meets the criteria, learn more about participation details here: https://lnkd.in/efSZrnZB #VEDS #ClinicalResearch #RareDisease